Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathy.
Vogt L, Chiurchiu C, Chadha-Boreham H, Danaietash P, Dingemanse J, Hadjadj S, Krum H, Navis G, Neuhart E, Parvanova AI, Ruggenenti P, Woittiez AJ, Zimlichman R, Remuzzi G, de Zeeuw D; PROLONG (PROteinuria Lowering with urOteNsin receptor antaGonists) Study Group. Vogt L, et al. Among authors: woittiez aj. Hypertension. 2010 May;55(5):1206-9. doi: 10.1161/HYPERTENSIONAHA.109.149559. Epub 2010 Mar 15. Hypertension. 2010. PMID: 20231521 Clinical Trial.
Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial.
Kwakernaak AJ, Krikken JA, Binnenmars SH, Visser FW, Hemmelder MH, Woittiez AJ, Groen H, Laverman GD, Navis G; Holland Nephrology Study (HONEST) Group. Kwakernaak AJ, et al. Among authors: woittiez aj. Lancet Diabetes Endocrinol. 2014 May;2(5):385-95. doi: 10.1016/S2213-8587(14)70030-0. Epub 2014 Mar 5. Lancet Diabetes Endocrinol. 2014. PMID: 24795252 Clinical Trial.
Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.
Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, Navis G, Laverman GD; HOlland NEphrology STudy Group. Slagman MC, et al. Among authors: woittiez aj. BMJ. 2011 Jul 26;343:d4366. doi: 10.1136/bmj.d4366. BMJ. 2011. PMID: 21791491 Free PMC article. Clinical Trial.
Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension.
Jansen PM, Frenkel WJ, van den Born BJ, de Bruijne EL, Deinum J, Kerstens MN, Arnoldus JH, Woittiez AJ, Wijbenga JA, Zietse R, Danser AH, van den Meiracker AH. Jansen PM, et al. Among authors: woittiez aj. J Hypertens. 2013 Feb;31(2):404-13. doi: 10.1097/HJH.0b013e32835b71d6. J Hypertens. 2013. PMID: 23249826
56 results